96 related articles for article (PubMed ID: 31319090)
1. NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.
Banerjee NS; Moore DW; Wang HK; Broker TR; Chow LT
Antiviral Res; 2019 Oct; 170():104559. PubMed ID: 31319090
[No Abstract] [Full Text] [Related]
2. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.
Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS
BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929
[TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin-proteasome system.
Jing K; Shin S; Jeong S; Kim S; Song KS; Park JH; Heo JY; Seo KS; Park SK; Kweon GR; Wu T; Park JI; Lim K
Cell Death Dis; 2014 Nov; 5(11):e1524. PubMed ID: 25393480
[TBL] [Abstract][Full Text] [Related]
5. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins.
Yablonska S; Hoskins EE; Wells SI; Khan SA
Microrna; 2013; 2(1):2-13. PubMed ID: 25070710
[TBL] [Abstract][Full Text] [Related]
6. Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.
Banerjee NS; Moore DW; Broker TR; Chow LT
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11138-E11147. PubMed ID: 30385631
[TBL] [Abstract][Full Text] [Related]
7. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
9. Targeting DNA Damage Response as a Strategy to Treat HPV Infections.
Banerjee NS; Moore D; Parker CJ; Broker TR; Chow LT
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683862
[TBL] [Abstract][Full Text] [Related]
10. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes.
Wang HK; Duffy AA; Broker TR; Chow LT
Genes Dev; 2009 Jan; 23(2):181-94. PubMed ID: 19131434
[TBL] [Abstract][Full Text] [Related]
11. E6/E7 Functional Differences among Two Natural Human Papillomavirus 18 Variants in Human Keratinocytes.
Nunes EM; Talpe-Nunes V; Sobrinho JS; Ferreira S; Lino VS; Termini L; Silva GÁF; Boccardo E; Villa LL; Sichero L
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200583
[TBL] [Abstract][Full Text] [Related]
12. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
13. Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.
Garner-Hamrick PA; Fostel JM; Chien WM; Banerjee NS; Chow LT; Broker TR; Fisher C
J Virol; 2004 Sep; 78(17):9041-50. PubMed ID: 15308700
[TBL] [Abstract][Full Text] [Related]
14. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.
Flores ER; Allen-Hoffmann BL; Lee D; Lambert PF
J Virol; 2000 Jul; 74(14):6622-31. PubMed ID: 10864676
[TBL] [Abstract][Full Text] [Related]
15. Promoting Vaginal Distribution of E7 and MCL-1 siRNA-Silencing Nanoparticles for Cervical Cancer Treatment.
Lechanteur A; Furst T; Evrard B; Delvenne P; Piel G; Hubert P
Mol Pharm; 2017 May; 14(5):1706-1717. PubMed ID: 28350964
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.
Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G
Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293
[TBL] [Abstract][Full Text] [Related]
17. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
18. HPV18 DNA replication inactivates the early promoter P
Wang X; Liu H; Wang HK; Meyers C; Chow L; Zheng ZM
Virol Sin; 2016 Oct; 31(5):437-440. PubMed ID: 27822719
[TBL] [Abstract][Full Text] [Related]
19. Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells.
Honegger A; Schilling D; Sültmann H; Hoppe-Seyler K; Hoppe-Seyler F
Methods Mol Biol; 2018; 1699():119-134. PubMed ID: 29086374
[TBL] [Abstract][Full Text] [Related]
20. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
